Perceptive Advisors’s Procept Biorobotics PRCT Stock Holding History

Perceptive Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-290,659	Closed	-$23.4M	–	104
2024 Q4	$23.4M	Sell	290,659 -25,000	-8%	-$2.14M	0.65%	38
2024 Q3	$25.3M	Buy	315,659 +105,000	+50%	+$7.46M	0.54%	49
2024 Q2	$12.9M	Hold	210,659	–	–	0.31%	64
2024 Q1	$10.4M	Buy	+210,659	New	+$10M	0.18%	76
2023 Q1	–	Sell	-64,537	Closed	-$2.68M	–	104
2022 Q4	$2.68M	Sell	64,537 -199,183	-76%	-$8.55M	0.08%	82
2022 Q3	$10.9M	Sell	263,720 -485,980	-65%	-$19.4M	0.32%	63
2022 Q2	$24.5M	Sell	749,700 -738,584	-50%	-$26.9M	0.77%	32
2022 Q1	$52.1M	Buy	1,488,284 +159,999	+12%	+$3.85M	1.04%	25
2021 Q4	$33.2M	Sell	1,328,285 -328,705	-20%	-$12.2M	0.51%	49
2021 Q3	$63.2M	Buy	+1,656,990	New	+$63.6M	0.92%	28

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perceptive Advisors's PRCT Position: Q1 2025 in Review

Perceptive Advisors sold out of Procept Biorobotics (PRCT) in Q1 2025, closing a stake of 290,659 shares — an estimated $23.4M sold.

Perceptive Advisors first reported a position in PRCT in Q3 2021 and held it in 10 quarters. The position peaked at $63.2M in Q3 2021. 279 funds tracked by Wall St. Rank hold PRCT as of Q1 2025.

Perceptive Advisors reported no remaining Procept Biorobotics position as of Q1 2025 after selling out during the quarter.
Perceptive Advisors sold 290,659 Procept Biorobotics shares in Q1 2025, an estimated $23.4M.
Perceptive Advisors first reported a position in Procept Biorobotics in Q3 2021 and held it in 10 quarters.
Perceptive Advisors's Procept Biorobotics position peaked at $63.2M in Q3 2021.
279 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2025.

Based on Perceptive Advisors's 13F filing for Q1 2025, filed 15 May 2025.